Abstract:Existing text-to-video (T2V) models often struggle with generating videos with sufficiently pronounced or complex actions. A key limitation lies in the text prompt's inability to precisely convey intricate motion details. To address this, we propose a novel framework, MVideo, designed to produce long-duration videos with precise, fluid actions. MVideo overcomes the limitations of text prompts by incorporating mask sequences as an additional motion condition input, providing a clearer, more accurate representation of intended actions. Leveraging foundational vision models such as GroundingDINO and SAM2, MVideo automatically generates mask sequences, enhancing both efficiency and robustness. Our results demonstrate that, after training, MVideo effectively aligns text prompts with motion conditions to produce videos that simultaneously meet both criteria. This dual control mechanism allows for more dynamic video generation by enabling alterations to either the text prompt or motion condition independently, or both in tandem. Furthermore, MVideo supports motion condition editing and composition, facilitating the generation of videos with more complex actions. MVideo thus advances T2V motion generation, setting a strong benchmark for improved action depiction in current video diffusion models. Our project page is available at https://mvideo-v1.github.io/.
Abstract:Neuronal morphology is essential for studying brain functioning and understanding neurodegenerative disorders. As the acquiring of real-world morphology data is expensive, computational approaches especially learning-based ones e.g. MorphVAE for morphology generation were recently studied, which are often conducted in a way of randomly augmenting a given authentic morphology to achieve plausibility. Under such a setting, this paper proposes \textbf{MorphGrower} which aims to generate more plausible morphology samples by mimicking the natural growth mechanism instead of a one-shot treatment as done in MorphVAE. Specifically, MorphGrower generates morphologies layer by layer synchronously and chooses a pair of sibling branches as the basic generation block, and the generation of each layer is conditioned on the morphological structure of previous layers and then generate morphologies via a conditional variational autoencoder with spherical latent space. Extensive experimental results on four real-world datasets demonstrate that MorphGrower outperforms MorphVAE by a notable margin. Our code will be publicly available to facilitate future research.
Abstract:Dynamic graphs arise in various real-world applications, and it is often welcomed to model the dynamics directly in continuous time domain for its flexibility. This paper aims to design an easy-to-use pipeline (termed as EasyDGL which is also due to its implementation by DGL toolkit) composed of three key modules with both strong fitting ability and interpretability. Specifically the proposed pipeline which involves encoding, training and interpreting: i) a temporal point process (TPP) modulated attention architecture to endow the continuous-time resolution with the coupled spatiotemporal dynamics of the observed graph with edge-addition events; ii) a principled loss composed of task-agnostic TPP posterior maximization based on observed events on the graph, and a task-aware loss with a masking strategy over dynamic graph, where the covered tasks include dynamic link prediction, dynamic node classification and node traffic forecasting; iii) interpretation of the model outputs (e.g., representations and predictions) with scalable perturbation-based quantitative analysis in the graph Fourier domain, which could more comprehensively reflect the behavior of the learned model. Extensive experimental results on public benchmarks show the superior performance of our EasyDGL for time-conditioned predictive tasks, and in particular demonstrate that EasyDGL can effectively quantify the predictive power of frequency content that a model learn from the evolving graph data.
Abstract:User interests are usually dynamic in the real world, which poses both theoretical and practical challenges for learning accurate preferences from rich behavior data. Among existing user behavior modeling solutions, attention networks are widely adopted for its effectiveness and relative simplicity. Despite being extensively studied, existing attentions still suffer from two limitations: i) conventional attentions mainly take into account the spatial correlation between user behaviors, regardless the distance between those behaviors in the continuous time space; and ii) these attentions mostly provide a dense and undistinguished distribution over all past behaviors then attentively encode them into the output latent representations. This is however not suitable in practical scenarios where a user's future actions are relevant to a small subset of her/his historical behaviors. In this paper, we propose a novel attention network, named self-modulating attention, that models the complex and non-linearly evolving dynamic user preferences. We empirically demonstrate the effectiveness of our method on top-N sequential recommendation tasks, and the results on three large-scale real-world datasets show that our model can achieve state-of-the-art performance.
Abstract:Machine learning has revolutionized many fields, and graph learning is recently receiving increasing attention. From the application perspective, one of the emerging and attractive areas is aiding the design and discovery of molecules, especially in drug industry. In this survey, we provide an overview of the state-of-the-art molecule (and mostly for de novo drug) design and discovery aiding methods whose methodology involves (deep) graph learning. Specifically, we propose to categorize these methods into three groups: i) all at once, ii) fragment-based and iii) node-by-node. We further present some representative public datasets and summarize commonly utilized evaluation metrics for generation and optimization, respectively. Finally, we discuss challenges and directions for future research, from the drug design perspective.